The committee is meeting for the first since Robert F. Kennedy Jr. abruptly dismissed all 17 members and replaced them with a ...

The CDC's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

CDC scientists presented data from the 2024-2025 season that showed RSV hospitalizations fell 28% to 43% among infants aged 0 to 7 months, compared with pooled rates from 2018 to 2020, when there ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) is recommending the use of Enflonsia ™ (clesrovimab-cfor) for the prevention of ...

It causes cold symptoms, affecting the breathing passages and lungs, according to the CDC. In the United States, about 58,000 children younger than 5 are hospitalized for RSV each year, and ...

(CNN) — A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend the use of a new shot that can protect babies ...

(Reuters) -Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group.